Metabolic syndrome and obesity are increasing epidemics that significantly impact the peripheral nervous system and lead to negative changes in sensation and peripheral nerve function. Research to understand the consequences of diet, obesity and fuel usage in sensory neurons has commonly focused on glucose metabolism. Here, we tested whether mouse sensory neurons and nerves have the capacity to metabolize fat-based fuels (palmitoyl-CoA) and whether these effects are altered by feeding of a ketogenic (90% kcal fat) diet compared with a control diet (14% kcal fat).
INTRODUCTION
The metabolism of fatty acids and mitochondrial function have been studied in numerous tissues and disease models to reveal the important roles of metabolism and mitochondria in chronic disease states (Lee, Olson, & Evans, 2003; Osborn & Olefsky, 2012; Reddy & Rao, 2006) . Studies examining the nervous system have primarily focused on brain metabolism of glucose or ketones and have largely neglected the examination of fatty acid metabolism. Likewise, peripheral nervous system metabolism has been extremely understudied and, to our knowledge, has been examined only for alterations in glucose metabolism (Akude et al., 2011; Chowdhury et al., 2010) . Only glucose metabolism may have been studied in the nervous system, because of the understanding that neurons in the CNS lack the isoform of carnitine palmitoyltransferase channels that allows long-chain fatty c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society acid transport into the mitochondria for proper fatty acidy oxidation (Price et al., 2002; Wolfgang et al., 2006) . However, the peripheral nervous system and, specifically, the dorsal root ganglion (DRG), are known to have the proper carnitine carrier and carnitine transferase enzymes required for mitochondrial fatty acid metabolism (Tonazzi, Mantovani, Colella, Terenghi, & Indiveri, 2013) . Emerging research has begun to recognize the key metabolic impact that peripheral nerves have in high-fat diet-induced obesity (Cooper et al., 2017; Groover et al., 2013; .
Ketone-based metabolism produces less damaging reactive oxygen species (ROS) compared with glucose metabolism at a mitochondrial and cellular level (Veech, 2004) . Fluorescent emission of H 2 O 2 has been used to examine the presence of ROS, because H 2 O 2 is the end product of the free radical O 2 molecule after processing by superoxide dismutase (Gomes, Fernandez, & Lima, 2005) . In neurons, reductions
New Findings
• What is the central question of this study? Do peripheral sensory neurons metabolize fat-based fuel sources, and does a ketogenic diet modify these processes?
• What is the main finding and its importance
We show that peripheral axons from mice fed a ketogenic diet respond to fat-based fuel sources with reduced respiration and H 2 O 2 emission compared with mice fed a control diet. These results add to our understanding of the responses of sensory neurons to neuropathy associated with poor diet, obesity and metabolic syndrome. These findings should be incorporated into current ideas of axonal protection and might identify how dietary interventions may change mitochondrial function in settings of sensory dysfunction.
in ROS owing to caloric restriction/ketone signalling might occur as a result of alterations in complex I of the respiratory chain. Additionally, ketones inhibit ROS production through an increase in the NAD/ NADH ratio while metabolizing -hydroxybutyrate compared with glutamate (Maalouf, Sullivan, Davis, Kim, & Rho, 2007) . Furthermore, this alteration in the NAD/NADH ratio is protective, because it engages Sirt1 to inhibit apoptotic and inflammatory signalling while putatively promoting increased mitochondrial biogenesis and reduced acetylation of mitochondrial proteins (Maalouf et al., 2007) . Improved mitochondrial respiration and/or reduced H 2 O 2 emission might offset detrimental mitochondrial changes associated with neuronal injury to improve neuronal health and healing.
One feature of metabolic dysfunction is an increase in mitochondrial dysfunction leading to an increase in ROS, which have been proposed to contribute to sensory dysfunction and neuropathy. Here, we show that mitochondria in the sciatic nerve (SN) of mice fed a high-fat, low-carbohydrate (ketogenic) diet adapt to fat-based fuel sources with reduced oxidative stress compared with mice fed a traditional diet. This reduction in ROS production, as shown by reduced H 2 O 2 emission, suggests that peripheral neurons can use a fat-based fuel source and can adapt to this fuel source when fed a ketogenic diet.
METHODS

Ethical approval and experimental protocol
All animal use was in accordance with the National Institutes of Health (NIH) Guide for the care and use of laboratory animals, eighth edition and conformed to the principles specified in a protocol approved by the University of Kansas Medical Center Institutional Animal Care and Use Committee (#2016-2324).
Seven-week-old male C57BL/6 CR #027 mice were purchased from Charles River (Wilmington, MA, USA) and maintained on a 12 h-12 h 
Body composition
Body composition to assess fat and lean mass was measured using the EchoMRI-100 (EchoMRI, Houston, TX, USA). The body composition was determined immediately before the animals were killed.
Glucose measurements
Mice underwent assessment for blood glucose (glucose diagnostic reagents; Sigma, St Louis, MO, USA) by tail vein nick after a 3 h fast.
Additionally, immediately after the animals were killed after a 3 h fast, blood was drawn from the chest cavity and allowed to clot for 30 min on ice, spun at 3000g for 30 min at 4 • C and serum drawn off and frozen at −80 • C until required for the analysis of insulin by enzyme-linked immunosorbent assay (Alpco, Salem, NH, USA).
Respiration and H 2 O 2 emission
Respiration and H 2 O 2 emission were measured using high-resolution respirometry and fluorescence (Oroboros Oxygraph-2k; Oroboros Instruments, Innsbruck, Austria). Protocols were based on O2k manual titrations for the substrate-uncoupler-inhibitor titration (SUIT) protocols for mitochondrial preparations. Isolated lumbar DRGs or both SNs were excised as previously described (Malin, Davis, & Molliver, 2007) , and the wet weights of both DRGs and SNs were determined before placement in respiration chambers. Both DRGs and SNs were permeabilized with 10 l digitonin (50 mg ml −1 ), briefly vortexed and placed on ice for 10 min. Nerves were then placed in respiration chambers with media (modified MiR05; sucrose, 110 mM; KMes, 60 mM; EGTA, 0.5 mM; MgCl 2 , 3 mM; KH 2 PO 4 , 10 mM; Hepes, 20 mM; and glucose, 20 mM; adjusted to pH 7.1 with KOH at 37 • C; and 1 g l −1 fatty acid-free bovine serum albumin) at 37 • C and a stir rate of 750 r.p.m. for assessment of respiration.
Basal oxygen flux was measured by addition of palmitoyl-CoA (2 mM), Mice fed a ketogenic diet for 10 weeks had increased body weight and increased fat mass compared with mice fed a control diet (n = 8 for both groups). No alterations in lean mass, fasting blood glucose or insulin were observed between groups (n = 8 for both groups). ***P < 0.001, ****P < 0.0001. malate (0.8 M), coenzyme A (12.5 mM) and carnitine (250 mM) to the chambers and measured after a steady state was achieved.
TA B L E 1 Measures of obesity and prediabetes
Palmitoyl-CoA and carnitine were added to the chamber separately to allow observation of differences in fatty acid transport into the mitochondria, as opposed to palmitoyl-carnitine, which some use Owing to the use of permeabilized whole tissue and the inability to inject mitochondria or lysate, H 2 O 2 calibration was done before the addition of tissue. Amplex UltraRed (10 M), horseradish peroxidase
(1 U ml −1 ) and superoxide dismutase (10 U ml −1 ; superoxide dismutase from bovine liver; Sigma-Aldrich, catalogue number S8160) were added to the chamber. 
RNAseq
Total RNA was extracted from lumbar DRGs 4, 5 and 6 from the second cohort of mice with the TruSeq Stranded mRNA Library Prep kit (Illumina, CA, USA). Six biological replicates were used for each dietary intervention group, for a total of 18 samples. Pair-end sequencing was performed using the Illumina platform, with a read length of 100 bp and an insert size of 160 bp. FastQC (https://www.bioinformatics.
babraham.ac.uk/projects/fastqc) was used to access sequence quality, with manual inspection of the results before proceeding to subsequent steps. The raw gene count data were obtained using RSEM (Li & Dewey, 2011) , with the default parameters. Within RSEM, we used bowtie2 (Langmead & Salzberg, 2012) as a mapping tool and the mouse mm10 genome assembly as the reference genome.
The Bioconductor package 'edgeR' (Robinson, McCarthy, & Smyth, 2010) was used for preprocessing the raw gene count data. Gene count data were normalized by library size, and genes with nontranscription/low transcription were removed. With regard to the latter, genes with expression level >1 c.p.m. in at least two of the 24 samples were retained, resulting in a total of ∼16,000 genes that were considered for subsequent statistical analyses. The resulting genes were then used to perform Kyoto Encylopedia of Genes and Genomes (KEGG) pathway analysis to examine all genes associated with known pathways using the Bioconductor package 'gage' (PMID: 19473525).
Mitochondrial oxidative phosphorylation pathways were examined for differences between mice fed the ketogenic diet and the control diet and visualized by the Bioconductor package 'pathview' (PMID: 23740750). These alterations shown before are differences in relative gene expression and have not been analysed for statistically significant alterations, but are instead used to show full complete pathway trends.
Statistical analyses
All data are presented as means ± SEM. Data were tested for normality using D'Agostino & Pearson test and then analysed using Student's unpaired t test. Statistical significance was defined as P < 0.05, and all statistics were run using either GraphPad Prism 7.0 (GraphPad Software Inc., La Jolla, CA) or R version 3.4.4 (https//cran.rproject.org).
RESULTS
Measures of obesity and prediabetes
Mice fed the ketogenic diet weighed significantly more than mice fed the control diet after 10 weeks on the diet (P < 0.001; Table 1 ). Mice fed the ketogenic diet also had increased fat mass compared with mice fed the control diet (P < 0.0001; Table 1 ). No changes in lean mass were observed in any group (Table 1 ). In addition, no significant alterations in blood glucose concentrations were observed (Table 1) .
Mitochondrial respiration of palmitoyl-CoA in DRG
Dorsal root ganglia harvested from mice consuming either a ketogenic or a control diet for 10 weeks displayed no differences in ADPstimulated (state III) or maximal uncoupled respiration of palmitoylCoA (Figure 1a,b) . Dorsal root ganglia also showed no differences in H 2 O 2 flux, a measure of ROS production, during metabolism of 
C o n t r o l -F e d K e t o g e n i c -F e d C o n t r o l -F e d K e t o g e n i c -F e d C o n t r o l -F e d K e t o g e n i c -F e d C o n t r o l -F e d K e t o g e n i c -F e d F I G U R E 1 Oxidative respiration and reactive oxygen species (ROS) production in dorsal root ganglion (DRG). (a) ADP-dependent (state III
Mitochondrial respiration of palmitoyl-CoA in sciatic nerve
Sciatic nerves from mice fed the control diet had elevated maximal uncoupled respiration compared with mice fed the ketogenic diet (P = 0.02), but they failed to reach a significant alteration in ADPstimulated (state III) respiration levels (P = 0.13; Figure 2a 
Gene expression in oxidative phosphorylation complexes
DISCUSSION
Mitochondrial function has become an important target in complications or diseases that affect the central and peripheral nervous systems. It is now becoming evident that the growing epidemic of obesity and metabolic syndrome is a probable contributor to neural dysfunction, and mitochondrial function is a key mediator in this process (Figueroa-Romero et al., 2008) . Even though in contains a high level of fat, a ketogenic diet has become popular as a disease intervention. In our own studies, we have shown that feeding mice 
C o n t r o l -F e d K e t o g e n i c -F e d C o n t r o l -F e d K e t o g e n i c -F e d F I G U R E 2 Oxidative respiration and ROS production in sciatic nerve (SN). (a) ADP-dependent (state III) respiratory rate of SN after 10 weeks of dietary challenge. (b) Maximal respiratory rate of SN (FCCP uncoupled). (c) State III rate of ROS production in SN. (d) ROS production during maximal respiratory rate in SN (FCCP uncoupled)
. n = 8 for all groups. All data are presented as means ± SD. * P < 0.05, ** P < 0.01 a ketogenic diet has a positive impact on peripheral nerve function and pain behaviours, independent of traditional metabolic benefits and physiological improvements (Cooper et al., 2018a) . As a clinical example, diabetes-associated peripheral neuropathy is thought to develop in part as a result of mitochondrial deficits (Chung, Prasad, & Lloyd, 2014) . It is not known how a ketogenic diet impacts diabetic neuropathy in human patients. Here, we show that a ketogenic diet appears to lead to adaptations in sensory neurons and axonal mitochondria to metabolize fat-based fuel sources, with reduced oxidative stress compared with mice fed a control diet. As we have shown previously, mice on a ketogenic diet did not lose weight and instead gained weight relative to control animals. This is contrary to the findings of many groups and might be attributable to the C57/Bl6 background substrain we used, beause we have recently seen key variations by substrain selection in the physiological effects of a highfat diet in C57BL/6 mice (Cooper et al., 2018a (Cooper et al., , 2018b . Additionally, a ketogenic diet appears to alter the gene expression of key components of the electron transport chain in the cell bodies of peripheral neurons.
Together, these results reveal modifications in peripheral nerve metabolism related to a ketogenic diet that should prove useful in the context of using a ketogenic diet as a dietary intervention.
There are numerous mechanisms that contribute to the development of peripheral neuropathy that can arise from poor metabolic health. One contributor to abnormal peripheral nerve function might be an increase in oxidative stress associated with mitochondrial dysfunction (Figueroa-Romero et al., 2008) . This idea suggests that during mitochondrial metabolism, an increase in ROS leads to increased lipid peroxidation and impaired mitochondrial function in the axon, with subsequent axonal degeneration (Fernyhough, Roy Chowdhury, & Schmidt, 2010) . Here, we have shown that peripheral neurons, axons and support cells can metabolize fats and that mice fed the control diet showed higher ROS production than mice fed the ketogenic diet. This suggests that peripheral neurons can adapt and metabolize fuels without an increase in ROS when challenged with dietary changes.
Based on the literature, an additional detrimental change in mitochondrial metabolism includes reduced enzymatic activity of complexes I and IV . 
F I G U R E 3
Relative gene expression of oxidative phosphorylation complex genes in DRG of mice fed a ketogenic diet compared with a control diet. For each mRNA, individual (n = 6) mice fed a ketogenic diet are represented by individual coloured bars placed over each gene name for their expression relative to mice fed a control diet. Green indicates a decrease in relative expression, red represents an increase in relative expression, and grey represents no relative change compared with mice fed a control diet (n = 6 for all groups). The colour scheme from −1 (green) to +1 (red) represents a log 2 fold change to a ketogenic diet. We interpret these changes to suggest that, contrary to mice fed the control diet, mice fed the ketogenic diet increase genes associated with complexes I and IV in order to increase mitochondrial activity, which is reduced in hyperglycaemic conditions. This is important because it has been reported that mitochondrial function and gene expression are negatively altered in the sensory neurons of animal models of type 1 diabetes .
Ketones can inhibit ROS production through an increase in the NAD/NADH ratio, and this could be a potential mechanism occurring in vivo that allows improved metabolism of fats (Fisher-Wellman & Neufer, 2012; Maalouf et al., 2007 ). An additional potential mechanism might be an alteration in ETF levels, because ETF can metabolize the FADH 2 produced in palmitoyl-CoA metabolism. Future studies should examine the potential role of ETF in the changes in fat metabolism in peripheral nerves. In our study, the reductions in mitochondrial H 2 O 2 flux in sciatic nerves during steady-state and maximal respiration suggest that mice fed the ketogenic diet have a decrease in ROS production when metabolizing fats. This metabolic improvement might identify the key adaptation that neurons adopt for metabolizing fats when fed a ketogenic diet. The diet-induced differences in mitochondria were observed only in the sciatic nerve, suggesting that mitochondria in distal components of peripheral nerve react to dietary changes in a different way to proximal mitochondria in the neuronal soma. This is also in agreement with the view that distal segments of peripheral nerves have a different susceptibility to metabolic dysfunction (Hinder, Vivekanandan-Giri, McLean, Pennathur, & Feldman, 2013) .
Conclusion
The present work highlights the impact of dietary changes on peripheral nerve mitochondria. We provide evidence that peripheral neurons and axon-associated cells can use a fat-based fuel source and can adapt to this fuel source when fed a ketogenic diet, leading to reduced ROS production. A ketogenic diet might be benefitical to neurons by reducing fat oxidation and the associated ROS production, which could improve peripheral nerve disease associated with poor mitochondrial function. These approaches might benefit peripheral axons and combat axonal degeneration, motor and sensory dysfunction and pain, which are experienced by millions of patients.
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